|
|
| (81 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| | <span style="display:none">forresearchers</span> |
| | <span style="display:none">forpatients</span> |
| | <span style="display:none">forproviders</span> |
| | <span style="display:none">forpolicymakers</span> |
| | <span style="display:none">croatiacountry</span> |
| | <span style="display:none">hospital</span> |
| | <span style="display:none">isCancerCenter</span> |
| [https://wiki.beaconcancer.org/index.php?title=Cancer_Centers Go back to Cancer Centers list.] | | [https://wiki.beaconcancer.org/index.php?title=Cancer_Centers Go back to Cancer Centers list.] |
| | | {{#set: |
| [[Croatia|See other cancer centers in Croatia.]] | | [[hasCoordinates::45.813039, 15.9433842]] |
| | | }} |
| == Trials == | | == [[hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials]] == |
| <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
| '''[https://wiki.beaconcancer.org/index.php?title=A_Study_Investigating_the_Outcomes_and_Safety_of_Atezolizumab_Under_Real-World_Conditions_in_Patients_Treated_in_Routine_Clinical_Practice_(IMreal)_(University_Hospital_for_Tumors_of_Zagreb) A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal)]'''
| |
|
| |
| [https://clinicaltrials.gov/ct2/show/NCT03782207?recrs=abdfm&cond=Cancer&locn=Clinical+Hospital+Center+Sestre+Milosrdnice%3B+Clinic+for+tumors&cntry=HR&draw=2&rank=2]
| |
|
| |
| '''Summary:''' This is a non-interventional, multi-country, multi-centre, multiple cohort prospective study, with retrospective collection of prior medical/treatment history data from medical records, designed to assess the real-world outcomes and safety of atezolizumab for indications in the existing label in the real world setting of routine clinical practice.
| |
|
| |
| '''Sponsor, manager, or home institution:''' Hoffmann-La Roche
| |
|
| |
| '''Intervention/Treatment:''' Drug: Atezolizumab
| |
|
| |
| '''Number of patients:''' 3400 participants
| |
|
| |
| '''Beginning Date:''' December 20, 2018
| |
|
| |
| '''Last Update:''' December 20, 2022
| |
|
| |
| '''Recruitment Status:''' Recruiting.
| |
|
| |
| '''Cancer areas of interest:''' Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Hepatocellular Carcinoma.
| |
|
| |
| '''[[A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) (KATE3) (University Hospital for Tumors of Zagreb)]'''
| |
| [https://clinicaltrials.gov/ct2/show/NCT04740918?recrs=abdfm&cond=Cancer&locn=University+Hospital+for+Tumors&cntry=HR&draw=1&rank=2]]
| |
|
| |
| '''Summary:''' This study will evaluate the efficacy, safety and patient-reported outcomes of trastuzumab emtansine plus atezolizumab compared with trastuzumab emtansine plus placebo in participants with HER2-positive and PD-L1-positive LABC or MBC.Participants must have progressed either during or after prior trastuzumab- (+/- pertuzumab) and taxane-based therapy for LABC/MBC; or during (or within 6 months after completing) trastuzumab- (+/-pertuzumab) and taxane-based therapy in the neoadjuvant and/or adjuvant setting.
| |
|
| |
| '''Sponsor, manager, or home institution:''' Hoffmann-La Roche
| |
|
| |
| '''Intervention/Treatment:'''
| |
| Drug: Trastuzumab Emtansine;
| |
| Drug: Atezolizumab;
| |
| Other: Placebo
| |
|
| |
| '''Number of patients:''' 320 participants
| |
|
| |
| '''Beginning Date:''' February 5, 2021
| |
|
| |
| '''Last Update:''' December 14, 2022
| |
|
| |
| '''Recruitment Status:''' Recruiting
| |
|
| |
| '''Cancer areas of interest:''' Metastatic Breast Cancer.
| |
| </div> | | </div> |
|
| |
|
| == Experts == | | == [[hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts]] == |
| <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
| '''[https://www.kbcsm.hr/klinike/klinika-za-tumore/anesteziologija-reanimacija-i-intezivno-lijecenje/ Department of Anesthesiology, Reanimatology and Intensive Treatment]'''
| |
|
| |
| '''[https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/ Department of Head and Neck Surgery]'''
| |
|
| |
| '''[https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-ginekolosko-onkolosku-kirurgiju/ Department of Gynecological-Oncological Surgery]'''
| |
|
| |
| '''[https://www.kbcsm.hr/klinike/klinika-za-tumore/onkoloska-patologija/ Department of Oncological Pathology and Clinical Cytology]'''
| |
|
| |
| '''[https://www.kbcsm.hr/zavod-za-internisticku-onkologiju/ Department of Internal Oncology]'''
| |
|
| |
| '''[https://www.kbcsm.hr/zavod-za-radioterapiju-i-onkologiju/ Department of Radiotherapy and Oncology]'''
| |
|
| |
| '''[https://www.kbcsm.hr/zavod-za-onkoplastiku-i-rekonstruktivnu-kirurgiju/ Institute for Oncoplastic and Reconstructive Surgery]'''
| |
|
| |
| '''[https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-onkoplastiku/ Department of Oncoplasty]'''
| |
| </div> | | </div> |
|
| |
|
| Line 71: |
Line 21: |
| <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| === Resource: Library of the University Hospital for Tumors === | | === [[hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums]] === |
|
| |
|
| '''Content Type:''' Library containing publications from the field of oncology and other biomedical subjects such as surgery, radiology, anesthesia, otorhinolaryngology, internal medicine, radiotherapy, etc. The library can also be used to search medical databases, bibliometric services and certificates, and other information. Librarians can help with instructions on how to find relevant literature. There are currently about 1,722 printed books and about 14,000 volumes of magazines (130 titles).
| | === [[hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours]] === |
|
| |
|
| '''Target Audience:''' Anyone in the region can access the library and create an account. The content is more relevant to providers and researchers.
| | === [[hasTraining::Training:_Specialist_Training_(University_Hospital_for_Tumours_of_Zagreb)|Training: Specialist Training]] === |
|
| |
|
| '''Data Access:''' [http://library.foi.hr/lib/index.php?page=&B=1409&H=&o=&K=&V=&D=&lok=&ogr=&upit= Library can be accessed here.]
| |
| <!--
| |
| === Other Learning Materials ===
| |
|
| |
| == [[Novel Therapies and Diagnostic Methods]] ==
| |
|
| |
| === Example ===
| |
|
| |
| '''Primary Purpose:'''
| |
|
| |
| '''Members:'''
| |
| -->
| |
| </div> | | </div> |
|
| |
|
| == Novel Therapies and Diagnostic Methods == | | == [[hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods]] == |
|
| |
|
| | == Cancer-related Patient Associations and Resources == |
| <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
|
| |
|
| === Diagnostics === | | === [[hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides]] === |
| | |
| {| class="wikitable"
| |
| ! Radiology !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Machine || CT scanners || Yes ||
| |
| |-
| |
| | Machine || Facilities for MRI (specify the strength and field of the techniques) || Yes ||
| |
| |-
| |
| | Machine || Mammography (please specify analogic mammography or digital) || Yes ||
| |
| |-
| |
| | Machine || Ultrasound || Yes ||
| |
| |-
| |
| | Technique || CT guided biopsis || Yes ||
| |
| |-
| |
| | Technique || E/S Fine-needle biopsy || Yes ||
| |
| |-
| |
| | Technique || Vacuum-assisted breast biopsy (VABB) || Yes ||
| |
| |-
| |
| | Technique || Angiography || Yes ||
| |
| |-
| |
| ! Nuclear Medicine !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Machine || PET Scan || Yes ||
| |
| |-
| |
| | Machine || PET CT || Yes ||
| |
| |-
| |
| | Machine || SPECT CT || Yes ||
| |
| |-
| |
| | Technique || Bone scintigraphy || Yes ||
| |
| |-
| |
| ! Pathology !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Facility || Cytology laboratory || Yes ||
| |
| |-
| |
| ! Pathology: Molecular Tests !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Technique || KRAS || Yes ||
| |
| |-
| |
| | Technique || EGFR || Yes ||
| |
| |-
| |
| | Technique || HER2 status || Yes ||
| |
| |-
| |
| | !! !! !!
| |
| |}
| |
| | |
| === Treatment ===
| |
|
| |
|
| {| class="wikitable"
| | === [[hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services]] === |
| ! Surgical Oncology !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Specialist || Gynaecological surgery || Yes ||
| |
| |-
| |
| | Machine || Ultrasonic Scapel || Yes ||
| |
| |-
| |
| ! Radiotherapy !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Machine || Linear accelerators || Yes ||
| |
| |-
| |
| | Machine || Linear accelerators with IMRT/VMAT || Yes ||
| |
| |-
| |
| | Machine || Respirator || Yes ||
| |
| |-
| |
| | Machine || Gamma Knife || Yes ||
| |
| |-
| |
| ! Hemato-Oncology / Bone Marrow Transplants !! !! !!
| |
| |-
| |
| | '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
| |
| |-
| |
| | Facility || Transfusion Unit || Yes | |
| |}
| |
|
| |
|
| | === [[hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts]] === |
| </div> | | </div> |
|
| |
|
| == EHDEN Participation == | | == [[isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation]] == |
| <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> | | <div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide"> |
| | </div> |
|
| |
|
| The Clinical Hospital Center “Sestre Milosrdnice” is part of the EHDEN Network of Data Partners.
| | __NOTOC__ |
| | | <span style="display:none">hasCoordinates::45.813039, 15.9433842</span> |
| The European Health Data and Evidence Network (EHDEN) aims to standardize European health data using OMOP-CDM to facilitate research. The project creates a federated network of data sources for easy access by researchers and policymakers. Its goal is to improve healthcare outcomes through better data quality and interoperability.
| | <span style="display:none">hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials</span> |
| | | <span style="display:none">hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts</span> |
| '''Primary purpose:''' To serve as an all-encompassing platform that manages various hospital processes from admission to discharge, with ongoing updates for medical, administrative, and legislative changes.
| | <span style="display:none">hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums</span> |
| | | <span style="display:none">hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours</span> |
| '''Type of information:''' The database contains patient-centric data covering a wide range of hospital activities, from appointments and diagnostics to nursing and transfers, structured up to CDA level 2 details.
| | <span style="display:none">hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods</span> |
| | | <span style="display:none">hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides</span> |
| '''Data level:''' Regional level.
| | <span style="display:none">hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services</span> |
| | | <span style="display:none">hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts</span> |
| '''Number of records:''' 600,000 patients.
| | <span style="display:none">isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation</span> |
| | | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> |
| '''Data range:''' 2010.
| | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> |
| | | <span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> |
| '''Open Data Access:''' Data is not publicly available. Instructions for data request [https://www.kbcsm.hr/o-bolnici/povjerenstva-kbc-sestre-milosrdnice/eticko-povjerenstvo/].
| | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> |
| | | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> |
| '''Contact information:''' Contact [https://www.kbcsm.hr/kontakt/].
| | <span style="display:none">hasCancerType::C40-C41: Bone cancers</span> |
| | | <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> |
| </div> | | <span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> |
| | <span style="display:none">hasCancerType::C50: Breast cancer</span> |
| | <span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> |
| | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> |
| | <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> |
| | <span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> |
| | <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> |
| | <span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> |
| | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> |
| | <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> |
| | <span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> |
| | <span style="display:none">hasCancerType::D10-D36: Benign tumour</span> |
| | <span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> |
| | <span style="display:none">hasCancerType::unknown</span> |
